Delivery Order SPE2DB20D3103-SPE2DB24FM3S0
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a firm fixed price of $1,544.32. The contract is for the supply of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product, to support Defense Logistics Agency (DLA) Troop Support Medical programs. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,632.26 firm fixed-price contract is for the delivery of Clindamycin PH 900 mg/6 ml vials. The award is not set-aside and has an ultimate completion date of June 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,848.65 contract is for the supply of a pharmaceutical product, Clindamycin 900 mg/50 ml-D5W 50 ml. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through December 31, 2025. The...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,277.84 award is for the supply of CLINDAMYCIN 900 MG/50 ML-D5W 50ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp, operating out of Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which does not have a...
- This federal contract award is for the delivery of CLINDAMYCIN PH 900 MG/6 ML VL 6ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract has a ceiling value of $4,627.25 and is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of May 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken,...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) was issued by the Defense Logistics Agency (DLA) for the delivery of 4,558,529,737 units of Clindamycin 900 mg/50 ml saline solution. The $4,451.05 firm fixed-price delivery order has a completion date of September 21, 2022 and was awarded on September 20, 2022. Amerisourcebergen, a major pharmaceutical distributor, is providing these medical supplies through an Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,048.20, is a Delivery Order for the supply of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a pharmaceutical product, with a performance period through December 31, 2024. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,697.30 Firm Fixed Price Delivery Order is for the supply of 4564428800 units of Clindamycin 900 mg/50 ml-D5W 50 ml. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,088.45 to AmerisourceBergen Drug Corp for Clindamycin PH 900 mg/6 mL vials on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price delivery order was competitively awarded without any set-aside designation. The pharmaceutical product will be supplied to support military healthcare operations, with the place of performance located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Clindamycin 600 mg/50 mL in D5W solution, with a ceiling value of $1,210.80. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be delivered to the company's facility in...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM3S0Delivery Order
This federal contract award is for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $27,286.19 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 23, 2024, with a completion date of January 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.